Imperial College London

ProfessorNicholaCooper

Faculty of MedicineDepartment of Immunology and Inflammation

Professor of Immune Haematology
 
 
 
//

Contact

 

n.cooper

 
 
//

Assistant

 

Miss Mandy Sale +44 (0)20 3313 4017

 
//

Location

 

4S10CCommonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Kuter:2019:10.1182/blood-2019-122336,
author = {Kuter, DJ and Boccia, RV and Lee, E-J and Efraim, M and Tzvetkov, N and Mayer, J and Trneny, M and Kostal, M and Hajek, R and McDonald, V and Bandman, O and Burns, R and Neale, A and Thomas, D and Cooper, N},
doi = {10.1182/blood-2019-122336},
publisher = {AMER SOC HEMATOLOGY},
title = {Phase I/II, Open-Label, Adaptive Study of Oral Bruton Tyrosine Kinase Inhibitor PRN1008 in Patients with Relapsed/Refractory Primary or Secondary Immune Thrombocytopenia},
url = {http://dx.doi.org/10.1182/blood-2019-122336},
year = {2019}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Kuter,DJ
AU - Boccia,RV
AU - Lee,E-J
AU - Efraim,M
AU - Tzvetkov,N
AU - Mayer,J
AU - Trneny,M
AU - Kostal,M
AU - Hajek,R
AU - McDonald,V
AU - Bandman,O
AU - Burns,R
AU - Neale,A
AU - Thomas,D
AU - Cooper,N
DO - 10.1182/blood-2019-122336
PB - AMER SOC HEMATOLOGY
PY - 2019///
SN - 0006-4971
TI - Phase I/II, Open-Label, Adaptive Study of Oral Bruton Tyrosine Kinase Inhibitor PRN1008 in Patients with Relapsed/Refractory Primary or Secondary Immune Thrombocytopenia
UR - http://dx.doi.org/10.1182/blood-2019-122336
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000518218500176&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER -